Poster Abstract  



Abstract Index

Forum Home

HST Home

Increased Systemic Production Of Carbon Monoxide In Patients With Cirrhosis And Ascites With And Without Spontaneous Bacterial Peritonitis

Andres Cardenas, MD
The Clinical Investigator Training Program
Harvard Medical School/MIT Health Sciences and Technology.

Division of Gastroenterology and Hepatology
Beth Israel Deaconess Medical Center
and The Liver Unit, Hospital Clinic, University of Barcelona, Spain.

Carbon monoxide (CO) is a gas with a potent vasodilator action synthetized from the catabolism of heme by the action of the heme oxygenase, which exists in two isoforms, constitutive (HO-2) and inducible (HO-l) by bac-terial products and cytokines. Studies in animals with portal hypertension have found an increased activity of the HO-I, which could participate in the pathogenesis of splanchnic vasodilation. No studies have been reported assessing the production of CO in human cirrhosis.

In the current study, the concentration of CO in the exhaled air (COexh) and the concentration of carboxihemoglobin in venous blood (COHb), as indexes of the systemic production of CO, were assessed in 16 healthy subjects, and 32 patients with cirrhosis (12 without ascites and 20 with ascites). Smokers and patients with lung diseases were excluded; COexh and COHb were significantly higher in patients with ascites than values in healthy subjects (p < 0.005 for both). In 19 patients with spontaneous bacterial peritonitis (SBP), values of COexh and COHb were even higher than those in patients with ascites without SBP (P < 0.01 for both). Resolution of SBP was associated with a significant reduction in both parameters, which reached values similar to those of patients without SBP one month after resolution on infection. In patients with SBP, high levels of COexh correlated with Child-Pugh score, plasma renin activity and serum levels of norepinephrine.

In conclusion, these results support the presence of an increased systemic production of CO in cirrhosis with ascites and SBP, which could participate in the pathogenesis of arterial vasodilation present in advanced cirrhosis.



Previous


Next


(last modified 3/12/03)